|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
|---|---|
| Information provided by: | Office of Rare Diseases (ORD) |
| ClinicalTrials.gov Identifier: | NCT00031122 |
Purpose
The purpose of this study is to describe the genetic contribution to the neural tube defects spina bifida (SB) and anencephaly (A), which includes identifying patients, defining the roles of certain genes, and studying gene-environment interactions.
| Condition | Intervention |
|---|---|
|
Spina Bifida Anencephaly |
Other: No Intervention |
| Study Type: | Observational |
| Study Design: | Family-Based, Retrospective |
| Official Title: | The Spina Bifida Research Resource |
DNA extracted from whole blood, saliva, buccal swab, and/or amniocytes
| Estimated Enrollment: | 1100 |
| Study Start Date: | September 2000 |
| Estimated Study Completion Date: | September 2012 |
| Estimated Primary Completion Date: | September 2011 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
SBRR
Families with a child/pregnancy affected with spina bifida or anencephaly
|
Other: No Intervention
There is no intervention in this study
|
The terms spina bifida and anencephaly include a range of developmental malformations that result from abnormal or incomplete closure of the neural tube. Despite advances in treatment and prenatal detection, these conditions remain as one of the most common and serious groups of birth defects. Spina bifida is associated with both increased mortality and morbidity, and anencephaly is always fatal. The occurrence of these conditions has a profound influence on affected individuals and their families and important public health implications. The etiology of NTDs has been of considerable interest for several decades. They are known to be etiologically heterogeneous and to occur in association with chromosome abnormalities, teratogenic exposures, and occasionally as part of single gene disorders. However, a specific causative agent cannot be identified in the vast majority of affected individuals. The etiology of NTDs in these "non-syndromic" patients is believed to be complex and to involve both genetic and environmental risk factors. Using a comprehensive research program, this study will evaluate the potential genetic determinants of SB and anencephaly in a large, well-characterized sample.
The family constellation used in this study consists of the proband (individual with an NTD - SB or A) and the proband's biologic parents and maternal grandparents. Blood or saliva samples are obtained from individuals and their families. Genomic DNA from all study participants is prepared from the samples, and genetic loci are evaluated. The proband, or his/her parents, complete a study questionnaire to obtain family history and epidemiologic information.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Volunteer participants recruited through support groups, clinics, and Web site responses
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Katy Hoess, MS | 866-275-SBRR (7277) | khoess@mail.med.upenn.edu |
| Contact: Barbara Weyland | 866-521-7289 | bweyland@ibt.tamhsc.edu |
| United States, Pennsylvania | |
| The University of Pennsylvania School of Medicine | Recruiting |
| Philadelphia, Pennsylvania, United States, 19104 | |
| United States, Texas | |
| The Texas A & M University Health Science Center | Recruiting |
| Houston, Texas, United States, 77030 | |
| Principal Investigator: Laura E. Mitchell, Ph.D. | |
| Principal Investigator: | Laura E. Mitchell, Ph.D. | The Texas A & M University Health Science Center |
More Information
| Responsible Party: | Institute for Biosciences and Technology, Texas A&M University ( Laura. E. Mitchell, Ph.D. ) |
| Study ID Numbers: | 1R01HD39195-01, 1R01HD39081-01 |
| Study First Received: | February 26, 2002 |
| Last Updated: | September 3, 2008 |
| ClinicalTrials.gov Identifier: | NCT00031122 |
| Health Authority: | United States: Federal Government |
|
Genetic Predisposition to Disease Environmental Exposure Chromosome Mapping Data Collection |
|
Neural Tube Defects Disease Susceptibility Nervous System Malformations Spinal Dysraphism Spina bifida |
Neural tube defect, folate-sensitive Genetic Predisposition to Disease Congenital Abnormalities Anencephaly |
|
Nervous System Diseases Monsters |
